# Novartis AG: Form 6-K, filed Feb 4, 2026

- Company: [Novartis AG](/companies/nvs.md) (CIK 1114448)
- Form: 6-K
- Filed: 2026-02-04
- Accepted by EDGAR: Feb 4, 2026, 06:51 ET
- Period: 2025-12-31
- Accession: 0001114448-26-000007
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000007/a260204-6k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1114448/000111444826000007/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1114448/000111444826000007/a260204-6k.htm

Filed Feb 4, 2026.
Source: SEC EDGAR, the filing index for accession 0001114448-26-000007. Last ingested by Listed: Nov 10, 2026, 04:31 ET. No prices; not investment advice.